The study involved 491 stroke survivors who were all prescribed drugs prior to hospital discharge aimed at preventing a second stroke by lowering cholesterol, reducing high blood pressure and preventing blood clots. Three months later, researchers evaluated the participants’ level of depression, quality of life, and whether they were still taking the stroke prevention drugs. A total of 385 people, or 78 percent, were still taking their medications after three months.
Nineteen percent of women reported feelings of depression, compared to ten percent of men. Thirty percent of women reported sleep problems, compared to 22 percent of men. But the men who kept taking their drugs reported a better overall quality of life than women who stuck with their medications.
“This study was consistent with others that have shown that women are more likely to keep taking their medications than men, even though they may be more likely to be depressed and have poorer quality of life,” said study author Cheryl Bushnell, MD, MHS, of Wake Forest University in Winston-Salem, NC, and member of the American Academy of Neurology. “It may be that depression and quality of life do not impact women’s motivation to take their medications. Men, on the other hand, who are more depressed and report poorer quality of life, are less likely to adhere to their medication schedules.”
MEDICA.de; Source: American Academy of Neurology